AKTX logo

Akari Therapeutics, Plc

AKTX
Healthcare|Biotechnology|US
$7.37
-0.38 (-4.90%)
DCF Value
$8.35
Cash / Share
$4.29
Next Earnings Report
Dec 4, 2026
EPS est. -$2.23
Financing Filings (last 12 months)
9
Shelf registrations / offering prospectuses — latest Jul 10, 2026 (S-3/A). Possible dilution.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Recent Press Releases

Akari Therapeutics to Highlight Novel RNA-Splicing ADC Payload Strategy at the 3rd Annual ADC Payload Summit
Oct 30, 2026 · GlobeNewsWire
Akari Therapeutics CEO Highlights Differentiated ADC Payload Strategy and Path Toward Clinical Development in New CEO Corner
Oct 15, 2026 · GlobeNewsWire
Akari Therapeutics Appoints Accomplished Oncology and ADC Deal Executive Vatnak Vat-Ho as Chief Business Officer to Drive Strategic Growth and Partnering
Oct 13, 2026 · GlobeNewsWire
Akari Therapeutics Expands Intellectual Property Portfolio with PCT Filing for ADC Payload Related to RNA Splicing in Cancers
Oct 1, 2026 · GlobeNewsWire
Akari Therapeutics Selected to Showcase Novel PH1 ADC Payload Platform at Leading Global Oncology, ADC and Healthcare Forums
Sep 8, 2026 · GlobeNewsWire
Akari Therapeutics Participates in the Virtual Investor "Why Now" On-Demand Conference
Aug 27, 2026 · GlobeNewsWire
Akari Therapeutics Builds Momentum for AKTX-101 with Compelling Urothelial Cancer Data Supporting Differentiated ADC Strategy
Aug 18, 2026 · GlobeNewsWire
Akari Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Progress of AKTX-101 Towards Phase 1 and Strategic Collaboration for Its ADC Payload Platform
Aug 13, 2026 · GlobeNewsWire

SEC Filings (88)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Oct 30, 2026S-8Employee stock planDocumentIndex
Oct 30, 20268-KMaterial eventDocumentIndex
Oct 1, 2026DEF 14AProxy / shareholder voteDocumentIndex
Oct 1, 20268-KMaterial eventDocumentIndex
Aug 13, 20268-KMaterial eventDocumentIndex
Aug 13, 202610-QQuarterly reportDocumentIndex
Aug 12, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 7, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jul 13, 2026EFFECTDocumentIndex
Jul 10, 2026S-3/AShelf registrationDocumentIndex
Jul 8, 2026S-3/AShelf registrationDocumentIndex
Jul 7, 2026EFFECTDocumentIndex
Jul 2, 20268-KMaterial eventDocumentIndex
Jul 2, 2026S-3Shelf registrationDocumentIndex
Jun 26, 20268-KMaterial eventDocumentIndex
Jun 26, 2026S-1/AIPO / offering registrationDocumentIndex
Jun 8, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jun 4, 2026DEF 14AProxy / shareholder voteDocumentIndex
Jun 3, 2026DDocumentIndex
May 22, 2026PRE 14AProxy / shareholder voteDocumentIndex
May 22, 20268-KMaterial eventDocumentIndex
May 21, 2026RWDocumentIndex
May 19, 202610-QQuarterly reportDocumentIndex
May 18, 2026NT 10-QDocumentIndex
May 8, 2026S-1IPO / offering registrationDocumentIndex
Apr 15, 2026EFFECTDocumentIndex
Apr 10, 2026POS AMDocumentIndex
Mar 31, 2026F-6/ADocumentIndex
Mar 30, 202610-KAnnual reportDocumentIndex
Mar 17, 20268-KMaterial eventDocumentIndex
Mar 4, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Mar 4, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Mar 4, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Mar 2, 20268-KMaterial eventDocumentIndex
Feb 2, 2026DEF 14AProxy / shareholder voteDocumentIndex
Jan 29, 2026EFFECTDocumentIndex
Jan 23, 2026S-1IPO / offering registrationDocumentIndex
Jan 22, 2026PRE 14AProxy / shareholder voteDocumentIndex
Dec 17, 20258-KMaterial eventDocumentIndex
Dec 17, 2025424B5Offering prospectusDocumentIndex